Vericel (NASDAQ:VCEL) develops, manufactures and markets autologous expanded cell therapies for the treatment of patients with serious diseases and conditions
REVOLUTION Medicines
19 followers
Summit Therapeutics
8 followers
Kymera Therapeutics
7 followers
Celldex Therapeutics
4 followers
Arcutis Biotherapeutics
3 followers
Biosynth
3 followers
Scholar Rock
1 follower
Olema Oncology
1 follower
Provivi
1 follower
Pharmacosmos
3 followers
Repertoire Immune Medicines
3 followers
Alloy Therapeutics
2 followers